198 related articles for article (PubMed ID: 34211033)
1. Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder.
Galván ST; Flores-López M; Romero-Sanchiz P; Requena-Ocaña N; Porras-Perales O; Nogueira-Arjona R; Mayoral F; Araos P; Serrano A; Muga R; Pavón FJ; García-Marchena N; de Fonseca FR
Sci Rep; 2021 Jul; 11(1):13629. PubMed ID: 34211033
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders.
García-Marchena N; Barrera M; Mestre-Pintó JI; Araos P; Serrano A; Pérez-Mañá C; Papaseit E; Fonseca F; Ruiz JJ; Rodríguez de Fonseca F; Farré M; Pavón FJ; Torrens M
PLoS One; 2019; 14(3):e0213791. PubMed ID: 30870525
[TBL] [Abstract][Full Text] [Related]
3. Differences among major depressive disorder with and without co-occurring substance use disorders and substance-induced depressive disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
Blanco C; Alegría AA; Liu SM; Secades-Villa R; Sugaya L; Davies C; Nunes EV
J Clin Psychiatry; 2012 Jun; 73(6):865-73. PubMed ID: 22480900
[TBL] [Abstract][Full Text] [Related]
4. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.
Beaulieu S; Saury S; Sareen J; Tremblay J; Schütz CG; McIntyre RS; Schaffer A;
Ann Clin Psychiatry; 2012 Feb; 24(1):38-55. PubMed ID: 22303521
[TBL] [Abstract][Full Text] [Related]
5. Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.
Winhusen T; Theobald J; Kaelber DC; Lewis D
Addiction; 2019 Aug; 114(8):1462-1470. PubMed ID: 30851217
[TBL] [Abstract][Full Text] [Related]
6. Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort.
Davis LL; Rush JA; Wisniewski SR; Rice K; Cassano P; Jewell ME; Biggs MM; Shores-Wilson K; Balasubramani GK; Husain MM; Quitkin FM; McGrath PJ
Compr Psychiatry; 2005; 46(2):81-9. PubMed ID: 15723023
[TBL] [Abstract][Full Text] [Related]
7. Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study.
Brenner P; Brandt L; Li G; DiBernardo A; Bodén R; Reutfors J
Addiction; 2019 Jul; 114(7):1274-1282. PubMed ID: 30938020
[TBL] [Abstract][Full Text] [Related]
8. Low plasma eicosapentaenoic acid levels are associated with elevated trait aggression and impulsivity in major depressive disorder with a history of comorbid substance use disorder.
Beier AM; Lauritzen L; Galfalvy HC; Cooper TB; Oquendo MA; Grunebaum MF; Mann JJ; Sublette ME
J Psychiatr Res; 2014 Oct; 57():133-40. PubMed ID: 25017608
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity.
Pavón FJ; Araos P; Pastor A; Calado M; Pedraz M; Campos-Cloute R; Ruiz JJ; Serrano A; Blanco E; Rivera P; Suárez J; Romero-Cuevas M; Pujadas M; Vergara-Moragues E; Gornemann I; Torrens M; de la Torre R; Rodríguez de Fonseca F
Addict Biol; 2013 Nov; 18(6):955-69. PubMed ID: 24283982
[TBL] [Abstract][Full Text] [Related]
10. Cocaine and depressive disorders: When standard clinical diagnosis is insufficient.
Alías-Ferri M; García-Marchena N; Mestre-Pintó JI; Araos P; Vergara-Moragues E; Fonseca F; González-Saiz F; Rodríguez de Fonseca F; Torrens M; Group N
Adicciones; 2021 Jul; 33(3):193-200. PubMed ID: 32100040
[TBL] [Abstract][Full Text] [Related]
11. Major depression in patients with substance use disorders: relationship to 12-Step self-help involvement and substance use outcomes.
Kelly JF; McKellar JD; Moos R
Addiction; 2003 Apr; 98(4):499-508. PubMed ID: 12653819
[TBL] [Abstract][Full Text] [Related]
12. Temperament and character dimensions in male patients with substance use disorders: Differences relating to psychiatric comorbidity.
Marquez-Arrico JE; López-Vera S; Prat G; Adan A
Psychiatry Res; 2016 Mar; 237():1-8. PubMed ID: 26921044
[TBL] [Abstract][Full Text] [Related]
13. Increased serum resistin but not G-CSF levels are associated in the pathophysiology of major depressive disorder: Findings from a case-control study.
Rahman S; Shanta AA; Daria S; Nahar Z; Shahriar M; Qusar MS; Islam SMA; Bhuiyan MA; Islam MR
PLoS One; 2022; 17(2):e0264404. PubMed ID: 35213631
[TBL] [Abstract][Full Text] [Related]
14. Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes.
Davis LL; Wisniewski SR; Howland RH; Trivedi MH; Husain MM; Fava M; McGrath PJ; Balasubramani GK; Warden D; Rush AJ
Drug Alcohol Depend; 2010 Mar; 107(2-3):161-70. PubMed ID: 19945804
[TBL] [Abstract][Full Text] [Related]
15. Primary and secondary substance misusers: do they differ in substance-induced and substance-independent mental disorders?
Bakken K; Landheim AS; Vaglum P
Alcohol Alcohol; 2003; 38(1):54-9. PubMed ID: 12554609
[TBL] [Abstract][Full Text] [Related]
16. Coexistence between personality disorders and substance use disorder. Madrid study about prevalence of dual pathology.
González E; Arias F; Szerman N; Vega P; Mesias B; Basurte I
Actas Esp Psiquiatr; 2019 Nov; 47(6):218-28. PubMed ID: 31869422
[TBL] [Abstract][Full Text] [Related]
17. Comorbid alcohol use disorder in psychiatric MDD patients: A five-year prospective study.
Holma M; Holma I; Isometsä E
J Affect Disord; 2020 Apr; 267():283-288. PubMed ID: 32217228
[TBL] [Abstract][Full Text] [Related]
18. Are depressed outpatients with and without a family history of substance use disorder different? A baseline analysis of the STAR*D cohort.
Davis LL; Frazier EC; Gaynes BN; Trivedi MH; Wisniewski SR; Fava M; Barkin J; Kashner TM; Shelton RC; Alpert JE; Rush AJ
J Clin Psychiatry; 2007 Dec; 68(12):1931-8. PubMed ID: 18162025
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity of Lifetime Alcohol Use Disorder and Major Depressive Disorder in San Juan, Puerto Rico.
Caetano R; Vaeth PAC; Canino G
J Stud Alcohol Drugs; 2019 Sep; 80(5):546-551. PubMed ID: 31603756
[TBL] [Abstract][Full Text] [Related]
20. Plasma Amino Acid Concentrations in Patients with Alcohol and/or Cocaine Use Disorders and Their Association with Psychiatric Comorbidity and Sex.
García-Marchena N; Marcos A; Flores-López M; Moreno-Fernández M; Requena-Ocaña N; Porras-Perales O; Torres-Galván S; Araos P; Serrano A; Muga R; Ruiz-Ruiz JJ; Rodríguez de Fonseca F; Ambrosio E; Pavón-Morón FJ
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
